IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q1 2016 Holdings

Filed 2016-05-13 | 19 holdings | $5.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cellectis(CLLS)SPONDS ADR15117K103$2.7M100,00053.4%
Adaptimmune(ADAPY)SPONDS ADR00653A107$2.0M250,00039.6%
Aurinia Pharma(AUPH)Common05156V102$256.0K88,3075.0%
ParatekCommon699374302$19.7K1,301,4130.4%
Chiasma(CHMA)Common16706W102$19.0K2,080,5950.4%
ProteonCommon74371L109$15.6K2,017,8720.3%
SientraCommon82621J105$15.0K2,199,0120.3%
CempraCommon15130J109$6.7K383,9350.1%
Dicerna(DRNAUSD)Common253031108$5.1K945,7570.1%
TobiraCommon88883P101$4.8K589,2440.1%
InnocollSPONDS ADR45780Q103$4.7K555,5550.1%
Lombard MedicalCommonG55598109$3.8K3,473,4520.1%
RegulusCommon75915K101$2.3K327,3500.0%
Cymabay(CBAYUSD)Common23257D103$2.2K1,600,0000.0%
AntheraCommon03674U201$1.6K437,9940.0%
Dermira(DERMEUR)Common24983L104$1.4K70,0000.0%
ChemoCentryx(CCXIEUR)Common16383L106$533215,0000.0%
Oncogenex PharmaCommon68230A106$271396,1040.0%
Epirus BiopharmaCommon29428P107$217,8960.0%